Major delay in Australian government’s Novavax deal, with 51m doses not expected until 2022

The Guardian

Initially touted as a ‘primary’ vaccine to help immunise Australia by the end of this year, Novavax will now form part of the booster strategy

July 27, 2021 • Sarah Martin

Loading tweets…
https://twitter.com/murpharoo/status/1419792532049784832

https://twitter.com/lukehgomes/status/1419788914760372227

https://twitter.com/msmarto/status/1419882227874205696

https://twitter.com/NassimKhadem/status/1420314935402237956

https://twitter.com/danielhurstbne/status/1419827103697039366

https://twitter.com/PSyvret/status/1419774056174297089

https://twitter.com/Sophiemcneill/status/1419865164455710720

https://twitter.com/SquigglyRick/status/1419789777654607873